Literature DB >> 26061621

The assembly and disassembly of the AcrAB-TolC three-component multidrug efflux pump.

Reinke Tobias Müller, Klaas Martinus Pos.   

Abstract

In Gram-negative bacteria, tripartite efflux pumps, like AcrAB-TolC from Escherichia coli, play a prominent role in the resistance against multiple antibiotics. Transport of the drugs across the outer membrane and its coupling to the electrochemical gradient is dependent on the presence of all three components. As the activity of the E. coli AcrAB-TolC efflux pump is dependent on both the concentration of substrates and the extent of the electrochemical gradient across the inner membrane, the dynamics of tripartite pump assembly and disassembly might be crucial for effective net transport of drugs towards the outside of the cell.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26061621     DOI: 10.1515/hsz-2015-0150

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  11 in total

1.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

Review 2.  A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.

Authors:  Shokufeh Ghasemian Sorboni; Hanieh Shakeri Moghaddam; Reza Jafarzadeh-Esfehani; Saman Soleimanpour
Journal:  Clin Microbiol Rev       Date:  2022-01-05       Impact factor: 26.132

3.  A palette of fluorophores that are differentially accumulated by wild-type and mutant strains of Escherichia coli: surrogate ligands for profiling bacterial membrane transporters.

Authors:  Jesus Enrique Salcedo-Sora; Srijan Jindal; Steve O'Hagan; Douglas B Kell
Journal:  Microbiology (Reading)       Date:  2021-02       Impact factor: 2.777

4.  The role of chemotaxis and efflux pumps on nitrate reduction in the toxic regions of a ciprofloxacin concentration gradient.

Authors:  Reinaldo E Alcalde; Christopher M Dundas; Yiran Dong; Robert A Sanford; Benjamin Keith Keitz; Bruce W Fouke; Charles J Werth
Journal:  ISME J       Date:  2021-04-29       Impact factor: 11.217

5.  Dynamics of Intact MexAB-OprM Efflux Pump: Focusing on the MexA-OprM Interface.

Authors:  Cesar A López; Timothy Travers; Klaas M Pos; Helen I Zgurskaya; S Gnanakaran
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

6.  An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump.

Authors:  Zhao Wang; Guizhen Fan; Corey F Hryc; James N Blaza; Irina I Serysheva; Michael F Schmid; Wah Chiu; Ben F Luisi; Dijun Du
Journal:  Elife       Date:  2017-03-29       Impact factor: 8.140

7.  The putative drug efflux systems of the Bacillus cereus group.

Authors:  Karl A Hassan; Annette Fagerlund; Liam D H Elbourne; Aniko Vörös; Jasmin K Kroeger; Roger Simm; Nicolas J Tourasse; Sarah Finke; Peter J F Henderson; Ole Andreas Økstad; Ian T Paulsen; Anne-Brit Kolstø
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

8.  Porcine Enterotoxigenic Escherichia coli Strains Differ in Their Capacity To Secrete Enterotoxins through Varying YghG Levels.

Authors:  Haixiu Wang; Raquel Sanz Garcia; Eric Cox; Bert Devriendt
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

9.  Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.

Authors:  Lisa Praski Alzrigat; Douglas L Huseby; Gerrit Brandis; Diarmaid Hughes
Journal:  J Antimicrob Chemother       Date:  2017-11-01       Impact factor: 5.790

10.  Impact of commonly used drugs on the composition and metabolic function of the gut microbiota.

Authors:  Arnau Vich Vila; Valerie Collij; Serena Sanna; Trishla Sinha; Floris Imhann; Arno R Bourgonje; Zlatan Mujagic; Daisy M A E Jonkers; Ad A M Masclee; Jingyuan Fu; Alexander Kurilshikov; Cisca Wijmenga; Alexandra Zhernakova; Rinse K Weersma
Journal:  Nat Commun       Date:  2020-01-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.